B-cell targeted therapy in systemic lupus erythematosus: potential of rituximab
E Wiesik-Szewczyk, M OlesinskaInstitute of Rheumatology, Department of Connective Tissue Diseases, Warsaw, PolandAbstract: Systemic lupus erythematosus (SLE) is a complex autoimmune disease of unknown etiology, and the limited available therapeutic options for this disease, are frustrating to both c...
Guardado en:
Autores principales: | Wiesik-Szewczyk E, Olesinska M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/432219feb2614506aef7b96cba088830 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Vesiculobullous disease with Cutaneous Systemic Lupus Erythematosus Treated by Rituximab: A case report
por: Wigdan Mohammed Niamat Alla, et al.
Publicado: (2021) -
Emerging B-Cell Therapies in Systemic Lupus Erythematosus
por: Bag-Ozbek A, et al.
Publicado: (2021) -
Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: an alternative to standard of care
por: Chessa E, et al.
Publicado: (2017) -
B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
por: Joseph M Tuscano, et al.
Publicado: (2009) -
B-CELL SUBPOPULATIONS OF PERIPHERAL BLOOD IN SYSTEMIC LUPUS ERYTHEMATOSUS
por: A. I. Budkova, et al.
Publicado: (2017)